International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
Oswaldo Cruz following year, Cruz was appointed director general of Public Health, a position corresponding to today's Brazilian Minister of Health. Using the Federal Serum Therapy Institute as technical-scientific base, he embarked in quick succession of important sanitation campaigns. His first challenge was a series of yellow fever endemics, which had earned Rio de Janeiro the sinister reputation of 'Foreigners' Grave'. Between 1897 and 1906, 4,000 European immigrants had died there from the disease. Cruz pursued the new technique of eradicating mosquitoes and their breeding grounds, fumigating houses, and isolation of the ill. There was opposition to the campaign by many, including